Skip to content

Multicenter randomized controlled clinical study of Longteng Tongluo Recipe in the treatment of lung cancer pain

Longteng Tongluo Recipe in Treating Lung Cancer Pain

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006504
Enrollment
Unknown
Registered
2022-08-16
Start date
2022-08-15
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer Pain

Interventions

Therapy group:Longteng Tongluo Fang + Three-step Pain Relief

Sponsors

Longhua hospital, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) Patients with cancer pain who are diagnosed with lung cancer by neurocytology, pathology and clinical and have a clear pain location. 2) Radiotherapy and chemotherapy (including radionuclide therapy) have been stopped for more than 1 month. 3) Those who can use external drugs and have no history of drug or food allergy. 4) Age =18 years old and =85 years old, good compliance. 5) Expected survival > 12 weeks. 6) The subjects have no major organ dysfunction and normal blood routine, liver, kidney and heart function. 7) Be able to understand the situation of this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) Those without a clear pathological diagnosis. 2) Patients undergoing radiotherapy and chemotherapy or less than 3 to 4 weeks after radiotherapy and chemotherapy. 3) The expected survival period is less than 3 months. 4) Combined with serious diseases such as heart, liver, kidney and hematopoietic system. 5) Pregnant or lactating patients detected by HCG. 6) Those with a history of uncontrollable mental illness.

Design outcomes

Primary

MeasureTime frame
NRS pain score;

Secondary

MeasureTime frame
Equivalent Morphine Consumption;Security indicators;

Countries

China

Contacts

Public ContactChangsheng Dong
18801615930@163.com18801615930

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026